Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)—A Critical Review
Dominika Jakubczyk, Katarzyna Leszczyńska, Sabina Górska
Nutrients (2020) Vol. 12, Iss. 7, pp. 1973-1973
Open Access | Times Cited: 242

Showing 1-25 of 242 citing articles:

Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD
Adrian Martyniak, Aleksandra Medyńska-Przęczek, Andrzej Wędrychowicz, et al.
Biomolecules (2021) Vol. 11, Iss. 12, pp. 1903-1903
Open Access | Times Cited: 142
Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives
Supriya Roy, Suneela Dhaneshwar
World Journal of Gastroenterology (2023) Vol. 29, Iss. 14, pp. 2078-2100
Open Access | Times Cited: 136
Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis
Xiaofeng Zhang, Xiao-Xian Guan, Yujun Tang, et al.
European Journal of Nutrition (2021) Vol. 60, Iss. 5, pp. 2855-2875
Closed Access | Times Cited: 134
Applications of synthetic biology in medical and pharmaceutical fields
Xu Yan, Xu Liu, Cuihuan Zhao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 67
Bifidobacterium and Lactobacillus improve inflammatory bowel disease in zebrafish of different ages by regulating the intestinal mucosal barrier and microbiota
Yinhua Ni, Yi Zhang, Liujie Zheng, et al.
Life Sciences (2023) Vol. 324, pp. 121699-121699
Closed Access | Times Cited: 42
Small intestine vs. colon ecology and physiology: Why it matters in probiotic administration
Benjamin A. H. Jensen, Marc Heyndrickx, Daisy Jonkers, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 9, pp. 101190-101190
Open Access | Times Cited: 41
A comprehensive review on the utilization of probiotics in aquaculture towards sustainable shrimp farming
C M Mathan Muthu, A.S. Vickram, B. Bhavani Sowndharya, et al.
Fish & Shellfish Immunology (2024) Vol. 147, pp. 109459-109459
Closed Access | Times Cited: 22
Mucosal host-microbe interactions associate with clinical phenotypes in inflammatory bowel disease
Shixian Hu, Arno R. Bourgonje, Ranko Gaćeša, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 18
Role of Probiotics against Human Cancers, Inflammatory Diseases, and Other Complex Malignancies
Hammad Naeem, Hammad Ul Hassan, Muhammad Shahbaz, et al.
Journal of Food Biochemistry (2024) Vol. 2024, pp. 1-23
Open Access | Times Cited: 15
Probiotics, Prebiotics and Synbiotics in Inflammatory Bowel Diseases
Katarzyna Akutko, Andrzej Stawarski
Journal of Clinical Medicine (2021) Vol. 10, Iss. 11, pp. 2466-2466
Open Access | Times Cited: 92
Dairy-Based Probiotic-Fermented Functional Foods: An Update on Their Health-Promoting Properties
Harpreet Kaur, Gurjeet Kaur, Syed Azmal Ali
Fermentation (2022) Vol. 8, Iss. 9, pp. 425-425
Open Access | Times Cited: 67
5-Aminosalicylic acid ameliorates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota and bile acid metabolism
Ling Huang, Junping Zheng, Guangjun Sun, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 8
Closed Access | Times Cited: 66
ROS-responsive hyaluronic acid hydrogel for targeted delivery of probiotics to relieve colitis
Lijie Huang, Junjie Wang, Lili Kong, et al.
International Journal of Biological Macromolecules (2022) Vol. 222, pp. 1476-1486
Closed Access | Times Cited: 62
Genetically engineered bacterium: Principles, practices, and prospects
Yiting Liu, Jing Feng, Hangcheng Pan, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 51
Probiotics and gut microbiota: mechanistic insights into gut immune homeostasis through TLR pathway regulation
Harpreet Kaur, Syed Azmal Ali
Food & Function (2022) Vol. 13, Iss. 14, pp. 7423-7447
Closed Access | Times Cited: 49
Inflammatory Bowel Disease Therapeutics: A Focus on Probiotic Engineering
Jayshree Mishra, Madyson Stubbs, Longxiang Kuang, et al.
Mediators of Inflammation (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 46
The effects of the probiotic cocktail on modulation of the NF-kB and JAK/STAT signaling pathways involved in the inflammatory response in bowel disease model
Shadi Aghamohammad, Amin Sepehr, Seyedeh Tina Miri, et al.
BMC Immunology (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 42
Live probiotic bacteria administered in a pathomimetic Leaky Gut Chip ameliorate impaired epithelial barrier and mucosal inflammation
So‐Youn Min, Nam Than, Yong Cheol Shin, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 40
The brain-gut-microbiota interplay in depression: A key to design innovative therapeutic approaches
Angelica Varesi, Lucrezia Irene Maria Campagnoli, Salvatore Chirumbolo, et al.
Pharmacological Research (2023) Vol. 192, pp. 106799-106799
Open Access | Times Cited: 39
Inflammatory bowel disease biomarkers of human gut microbiota selected via different feature selection methods
Burcu Bakır-Güngör, Hilal Hacılar, Amhar Jabeer, et al.
PeerJ (2022) Vol. 10, pp. e13205-e13205
Open Access | Times Cited: 38
Alginate Oligosaccharides Prevent Dextran-Sulfate-Sodium-Induced Ulcerative Colitis via Enhancing Intestinal Barrier Function and Modulating Gut Microbiota
Axue Wu, Yuan Gao, Ruotong Kan, et al.
Foods (2023) Vol. 12, Iss. 1, pp. 220-220
Open Access | Times Cited: 29
Probiotics for the treatment of depression and its comorbidities: A systemic review
Jie Gao, Na Zhao, Yiwen Cheng, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 28
Bacteroides acidifaciens and its derived extracellular vesicles improve DSS-induced colitis
Cihua Zheng, Yuchun Zhong, Jian Xie, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 24
The emerging role of the gut microbiota and its application in inflammatory bowel disease
Wang Xiu, Jianhua Peng, Pei-Pei Cai, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117302-117302
Open Access | Times Cited: 11
A tailored series of engineered yeasts for the cell-dependent treatment of inflammatory bowel disease by rational butyrate supplementation
Jiahao Wu, He Huang, Lina Wang, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top